See the DrugPatentWatch profile for keytruda

Financial Assistance Programs for Keytruda: A Lifeline for Patients

What is Keytruda?

Keytruda, also known as pembrolizumab, is a medication used to treat various types of cancer, including melanoma, non-small cell lung cancer, head and neck cancer, and classical Hodgkin lymphoma. It is a type of immunotherapy that works by boosting the body's natural defenses to fight cancer cells.

The High Cost of Keytruda

While Keytruda has been shown to be effective in treating various types of cancer, it comes with a hefty price tag. The cost of Keytruda can range from $12,000 to $15,000 per month, depending on the dosage and treatment regimen. This can be a significant financial burden for patients, especially those who are uninsured or underinsured.

Financial Assistance Programs for Keytruda

Fortunately, there are several financial assistance programs available to help patients afford Keytruda. Here are a few options:

1. Merck Patient Assistance Program

Merck, the manufacturer of Keytruda, offers a patient assistance program that provides free or low-cost medication to eligible patients. To be eligible, patients must have a household income of $100,000 or less and have no insurance or inadequate insurance coverage.

2. Patient Access Network (PAN)

PAN is a non-profit organization that provides financial assistance to patients with chronic and life-threatening diseases, including cancer. They offer a Keytruda co-pay program that helps patients pay for their medication.

3. CancerCare Co-Payment Assistance Foundation

The CancerCare Co-Payment Assistance Foundation provides financial assistance to patients with cancer, including those taking Keytruda. They offer a co-pay program that helps patients pay for their medication and other cancer-related expenses.

4. DrugPatentWatch.com

According to DrugPatentWatch.com, a website that tracks pharmaceutical patents, Keytruda's patent is set to expire in 2028. This means that generic versions of the medication may become available, which could lead to lower prices and increased access.

5. Manufacturer Coupons and Discounts

Merck also offers various coupons and discounts for Keytruda, including a savings program for eligible patients and a discount card for patients with commercial insurance.

How to Access Financial Assistance Programs

To access financial assistance programs for Keytruda, patients can:

* Contact the manufacturer's patient assistance program directly
* Visit the websites of non-profit organizations that offer financial assistance programs
* Consult with their healthcare provider or a patient advocate

Conclusion

Keytruda is a life-saving medication for many patients with cancer, but its high cost can be a significant barrier to access. Fortunately, there are several financial assistance programs available to help patients afford this medication. By exploring these options, patients can access the treatment they need and focus on their recovery.

FAQs

Q: Who is eligible for the Merck Patient Assistance Program?

A: Patients with a household income of $100,000 or less and no insurance or inadequate insurance coverage are eligible for the Merck Patient Assistance Program.

Q: How do I apply for the Patient Access Network (PAN) Keytruda co-pay program?

A: Patients can apply for the PAN Keytruda co-pay program by visiting the PAN website and completing an application.

Q: Can I get financial assistance for Keytruda if I have commercial insurance?

A: Yes, patients with commercial insurance may be eligible for financial assistance programs, including manufacturer coupons and discounts.

Q: How long will Keytruda's patent last?

A: According to DrugPatentWatch.com, Keytruda's patent is set to expire in 2028.

Q: Can I get financial assistance for Keytruda if I have Medicare or Medicaid?

A: Yes, patients with Medicare or Medicaid may be eligible for financial assistance programs, including the Merck Patient Assistance Program and non-profit organizations that offer financial assistance programs.

Sources:

1. Merck. (n.d.). Patient Assistance Program. Retrieved from <https://www.merck.com/about/merck-across-healthcare/ patient-assistance-program.html>
2. Patient Access Network (PAN). (n.d.). Keytruda Co-Pay Program. Retrieved from <https://www.panfoundation.org/programs/keytruda-co-pay-program>
3. CancerCare Co-Payment Assistance Foundation. (n.d.). Keytruda Co-Pay Program. Retrieved from <https://www.cancercarecopay.org/programs/keytruda-co-pay-program>
4. DrugPatentWatch.com. (n.d.). Pembrolizumab (Keytruda) Patent. Retrieved from <https://www.drugpatentwatch.com/patent/US-9248461>
5. Merck. (n.d.). Savings Program. Retrieved from <https://www.merck.com/about/merck-across-healthcare/savings-program.html>